This study is designed to investigate whether the adoption of the use of a range of wound care products from a single manufacturer makes training in appropriate product selection more effective and results in more accurate selection of the appropriate product for the wound and for the patient's lifestyle, thereby incurring less waste and reducing the number of referrals by the community nursing team to the Tissue Viability Team. One community nursing team will switch to using a full range of dressings and compression products from BSN medical UK for three months. Nurse training on the products will be given and nurse competencies and confidence in woundcare and appropriate product selection will be tested at the start and end of the study. The number and type of referrals to the Tissue Viability Team will be measured. Total anonymised data on numbers of referrals, wound closure, numbers of wounds and quantity and cost of products used will be collected and compared with the historical record for three months prior to the study. Patients will complete a Quality of Life questionnaire at enrolment and exit from the study. Patients for whom BSN medical UK products are not appropriate or not desired by the patient will not be enrolled and will receive the usual range of products available to the community nursing team.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Enrollment
21
The participating Healthcare Professionals will be asked to use BSN medical wound care products for the study duration
South West Essex Community Services, North East London NHS Foundation Trust, Brentwood Community Hospital
Brentwood, Essex, United Kingdom
Incidence of inappropriate use of dressings for the wound condition and patient lifestyle
As measured by referrals for case review to the Tissue Viability Team during the study
Time frame: At the end of 12 weeks treatment period
Number of patients with wounds treated
Time frame: At the end of 12 weeks treatment period
Wound types treated
Time frame: At the end of 12 weeks treatment period
Total number of wound closure occurred
Time frame: At the end of 12 weeks treatment period
Average duration of treatment
Time frame: At the end of 12 weeks treatment period
Patients Quality of Life living with a Wound
as measured by use of the validated questionnaire Wound QoL.
Time frame: At the start of the study and at the end of 12 weeks treatment period
Confidence of healthcare professionals in their dressing selection
as measured by written assessment
Time frame: At the start of the study and at the end of 12 weeks treatment period
Visual Analogue Scoring by the healthcare professionals of the simplification of training
Time frame: At the end of 12 weeks treatment period
Time required for training
Time frame: At the end of 12 weeks treatment period
NHS Trainer's time
Time frame: At the end of 12 weeks treatment period
NHS Trainer's cost
Time frame: At the end of 12 weeks treatment period
Nurse's concordance with training measured by the total number of referrals to the tissue viability team caused by inappropriate dressing selections defined by the trust's guidelines
Time frame: At the end of 12 weeks treatment period
Costs of dressings used
Time frame: At the end of 12 weeks treatment period
Number of wounds which could not be treated by the integrated range
Time frame: At the end of 12 weeks treatment period
Condition of wounds which could not be treated by the integrated range
Time frame: At the end of 12 weeks treatment period
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.